// App-Quantinova.ai

19260 : Prothrombotic Activity and Reduction in Coronary Flow Reserve Associated With Therapeutic Intracoronary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells is Ameliorated by Heparin Co-Administration in a Porcine Myocardial Infarction Model

Researchers

Presenter

  • Kenneth Martin

Principal Investigators

  • Arun HS Kumar

  • Mohammed T Ali

  • Frank P Barry

  • Timothy -Brien

  • Noel M Caplice

Medical Centers

  • University College Cork, Cork, Ireland

  • The National University of Ireland, Galway, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Mesenchymal stem cells

  • Thomsen-Friedenreich antigen

Drug/Treatment

  • Evithrom

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim